Effect of High-Frequency Vibration on Periodontal Tooth Mobility

Tooth Mobility Clinical Trial

Official title: Effect of High-Frequency Vibration on Periodontal Tooth Mobility

Status Completed

Clinical Trial Summary

According to the CDC, approximately 47% of the population suffers from moderate or severe periodontitis. A byproduct of periodontal disease is loss of the alveolar bone surrounding the natural tooth root as well as around the dental implant in cases of peri-implantitis, and if allowed to proceed far enough, can cause mobility and eventual loss of the tooth or implant. Traditional and time-tested methods of treating periodontitis involve a meticulous mechanical cleaning of the root surfaces to remove the causing factors, both above and below the gumline. This reduction or elimination of the etiologic factors that trigger the pathologic and damaging immune response is very effective at reducing the inflammation. High Frequency Vibration (VPro+), when used as an adjunctive therapy following traditional treatment for periodontitis where the chronic inflammation has been lowered, controlled or eliminated has the potential to enhance the mechanical properties of the bone by increasing bone density by way of a low-risk, non-invasive, self-applied therapy that is patient-friendly and affordable. Improvement in bone density can translate clinically to lowering of tooth mobility, and lessening the chance of orthodontic relapse after orthodontic therapy. It is further hypothesized that, if conducted in an environment of low or nonexistent periodontal inflammation, VPro+ therapy may also contribute to enhanced the degree of bone fill after healing of angular periodontal bone defects and low-grade furcation involvements, and as thus may turn out to be a less invasive and more affordable option to periodontal bone grafting surgery, the current standard of care for those particular situations. The goal is to conduct a randomized clinical trial using patients in our graduate periodontology program to test the efficacy of high frequency vibration in improvement of tooth mobility and other periodontal indices in test group versus control group.

Clinical Trial Description

Background Bio stimulation of hard and soft tissue to enhance or accelerate healing is an exciting area of inquiry with the potential to have broad clinical application in periodontics. The external application of energy in the form of light (e.g. Lasers or broad-spectrum light) (1) or mechanical waves (ultrasonic or high-frequency vibration) (2),(3) has shown efficacy in creating clinical changes in hard and soft tissue that can be very positive and beneficial or the contrary, depending on the application and the existing initial conditions present. According to the CDC, approximately 47% of the population suffers from moderate or severe periodontitis. (4) This chronic disease is a systemic disease that is fundamentally connected to other diseases of inflammation, including diabetes, arthritis, Alzheimer's Disease, and heart disease(5) and is, therefore, a disease that should not be taken lightly. A by-product of periodontal disease is the loss of the alveolar bone surrounding the natural tooth root as well as around the dental implant in cases of peri-implantitis, and if allowed to proceed far enough can cause mobility and eventual loss of the tooth or dental implant. The chronic inflammatory process results in the destruction of both hard and soft tissues and is triggered in the susceptible host by microbial biofilm and mineralized biofilm (i.e. calculus). Traditional and time-tested methods of treating periodontitis involve a meticulous mechanical cleaning of the root surfaces to remove the causing factors, both above and below the gum line. This reduction or elimination of the etiologic factors that trigger the pathologic and damaging immune response is very effective at reducing inflammation. High-Frequency Vibration (VPro+), when used as an adjunctive therapy following traditional treatment for periodontitis wherein the chronic inflammation has been lowered, controlled, or eliminated has the potential to enhance the mechanical properties of the bone by increasing bone density (3) by way of a low-risk, non-invasive, self-applied therapy that is patient-friendly and affordable. Improvement in bone density can translate clinically to lowering (i.e. improvement) of tooth mobility and lessening the chance of orthodontic relapse after orthodontic therapy. It is further hypothesized that, if conducted in an environment of low or nonexistent periodontal inflammation, VPro+ therapy may also contribute to enhancing the degree of bone fill after healing of angular periodontal bone defects and low-grade furcation involvements, and as thus may turn out to be a less invasive and more affordable option to periodontal bone grafting surgery, the current standard of care for those particular situations. Tissue Response to VPro+ Application in areas of Inflammation It is clear from previous research into the use of the VPro+ to accelerate and enhance orthodontic therapy that the cellular tissue response in areas of inflammation is essentially the opposite to that which occurs in areas of no inflammation. (3) Again, whether the response is beneficial depends on the intended application at hand. VPro+ therapy in areas of inflammation caused by orthodontic tooth movement forces stimulates osteoclastic activity to accelerate the resorption of bone, making the bone "softer" and thus allowing for more rapid tooth movement through these softer areas. On the contrary, when considering periodontitis, it is critical to understand that the inflammation must first be lowered and controlled so that the tissue response is anabolic, not catabolic. Our goal in periodontal therapy is to preserve, regenerate and strengthen the periodontal tissues, including the bone. So, a mandatory precursor therapy to using the VPro+ in cases of periodontitis is to first perform periodontal therapy and demonstrate and document a reduction or elimination of chronic inflammation by way of a Re-Evaluation Examination. Expected result of this study We expect that VPro+ will safely enhance the condition of the periodontal tissues around the teeth in periodontal patients in a periodontal recall program and that this enhancement will improve the long-term prognoses of the teeth. Study design This randomized, single blind clinical trial will enroll from 10-20 subjects from an established graduate periodontology program who have previously been treated for periodontal disease and are now in a periodontal recall program. These patients will be randomized between the two groups. The evaluator examining the patients will be blinded to the group assignment as the coding will be kept separate from the clinical patient record. The subjects, however, will be aware of whether they are in the treatment or no-treatment control group. Specific Aims of the study: This clinical trial aims to answer these questions: 1. Will the vibration produced by the VPro+ device improve (i.e. lessen) the mobility of periodontally compromised teeth for periodontal patients in a periodontal recall program? 2. Will the vibration produced by the VPro+ device improve the periodontal condition around teeth as measured by the standard periodontal indices in periodontal patients who are in a periodontal recall program? 3. Will the vibration produced by the VPro+ device improve the appearance of angular bone defects on routine radiographs (i.e. give the appearance of partial or complete fill of the bone defect) in periodontal patients in a periodontal recall program? 4. Will the vibration produced by the VPro+ device improve (i.e. increase) the bone density as measured by CBCT analysis in periodontal patients in a periodontal recall program? Study Groups To address this specific aim, patient will be divided into 2 groups: Group 1 (Treatment) This group will use the VPro+ device for 5 minutes every night for 3 months Group 2 (No Treatment) This group will be given a sham VPro+ device and thus serve as the control group. Methods and procedures This is a randomized, single blinded clinical trial. The subjects will be patients with a history of treated periodontal disease that are currently in and compliant with a periodontal recall program in an established periodontal specialty practice. The subjects will be randomized between 2 groups. Group 1 is the treatment group and will receive the VPro+ device to use 5 minutes per night for 3 months. Group 2 is the no-treatment (control) group that will have access to the sham VPro+ device. Patient will be asked to bite comfortably on VPro+ for a total of 5 minutes per day, preferably just before bedtime. Compliance will be collected from the VPro+ using the Propel Application on the subjects' smartphone. Data collection, data analysis and monitoring A designated clinical study coordinator will be assigned by the Principal Investigator. Good Clinical Practices (GCP) will be implemented for this study. The designee will review the Case Report Forms (CRF) for completeness and assess them for any product complaints, potential adverse events and/or medical device reports per the Health Canada regulations. Any missing entries in the CRFs will be brought to the Investigator or study coordinator's attention for correction. Potential Benefits to the Subject In patients with periodontal disease and bone loss that have already been treated by traditional methods, we anticipate that the bone density and mechanical properties of the bone may increase (i.e. improve) in patients receiving HFV therapy. This can have the effect of lowering the mobility of some of the teeth. Even so, the subject may not get any benefit from being in this research study. This study may help people in the future who are in periodontal recall programs. Subjects (i.e. patients) who complete the study will not be charged for any of the care delivered during the study. Once the study is over, patients will go back on their normal periodontal recall program. ;

Related Conditions & MeSH terms

• Tooth Mobility

• NCT number: NCT05460091
• Study type: Interventional
• Source: University of Alberta
• Status: Completed
• Phase: Phase 1
• Start date: July 1, 2021
• Completion date: March 30, 2022